RSV-F Vaccine Dose Ranging Study in Young Women

PHASE2CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Respiratory Syncytial Virus (RSV)
Interventions
BIOLOGICAL

Low dose RSV-F Vaccine with Adjuvant

0.5mL IM Injection

BIOLOGICAL

Low dose RSV-F Vaccine without Adjuvant

0.5ml IM Injection

BIOLOGICAL

High dose RSV-F Vaccine with Adjuvant

0.5mL IM Injection

BIOLOGICAL

High dose RSV-F Vaccine without Adjuvant

0.5mL IM Injection

BIOLOGICAL

Low dose RSV-F Vaccine with Adjuvant [Bedside Mixing]

0.5mL IM Injection

BIOLOGICAL

Placebo

0.5mL IM Injection

Trial Locations (4)

20850

Accelovance Rockville, Rockville

29464

Coastal Carolina Research, Mt. Pleasant

78229

Clinical Trials of Texas, San Antonio

92801

Anaheim Clinical Trials, Anaheim

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

PATH

OTHER

lead

Novavax

INDUSTRY